Genetics Clinics Australia

Melbourne, Victoria 3161

0 studies enrolling now · 4 studies all time

What they study most

22Q11.2 Deletion Syndrome, Fragile X Syndrome

Studies at this site

• Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS — Running, not enrolling
• Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE) — Completed
• Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome — Completed
• Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX) — Completed